Evidence map›Paper›PMID 36174073›Full record

ArticlePloS one2022

Deep fusion of gray level co-occurrence matrices for lung nodule classification.

Ahmed Saihood, Hossein Karshenas, Ahmad Reza Naghsh Nilchi

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ahmed SaihoodArtificial Intelligence Department, Faculty of Computer Engineering, University of Isfahan, Isfahan, Iran.ORCID 0000-0002-0147-7121
Hossein KarshenasArtificial Intelligence Department, Faculty of Computer Engineering, University of Isfahan, Isfahan, Iran.
Ahmad Reza Naghsh NilchiArtificial Intelligence Department, Faculty of Computer Engineering, University of Isfahan, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is a serious threat to human health, with millions dying because of its late diagnosis. The computerized tomography (CT) scan of the chest is an efficient method for early detection and classification of lung nodules. The requirement for high accuracy in analyzing CT scan images is a significant challenge in detecting and classifying lung cancer. In this paper, a new deep fusion structure based on the long short-term memory (LSTM) has been introduced, which is applied to the texture features computed from lung nodules through new volumetric grey-level-co-occurrence-matrices (GLCMs), classifying the nodules into benign, malignant, and ambiguous. Also, an improved Otsu segmentation method combined with the water strider optimization algorithm (WSA) is proposed to detect the lung nodules. WSA-Otsu thresholding can overcome the fixed thresholds and time requirement restrictions in previous thresholding methods. Extended experiments are used to assess this fusion structure by considering 2D-GLCM based on 2D-slices and approximating the proposed 3D-GLCM computations based on volumetric 2.5D-GLCMs. The proposed methods are trained and assessed through the LIDC-IDRI dataset. The accuracy, sensitivity, and specificity obtained for 2D-GLCM fusion are 94.4%, 91.6%, and 95.8%, respectively. For 2.5D-GLCM fusion, the accuracy, sensitivity, and specificity are 97.33%, 96%, and 98%, respectively. For 3D-GLCM, the accuracy, sensitivity, and specificity of the proposed fusion structure reached 98.7%, 98%, and 99%, respectively, outperforming most state-of-the-art counterparts. The results and analysis also indicate that the WSA-Otsu method requires a shorter execution time and yields a more accurate thresholding process.

Indexed as

Lung NeoplasmsAlgorithmsHumansTomography, X-Ray Computed

Identifiers

PMID36174073
PMCPMC9521911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.